Code of Conduct
Supporting the SDGs Goals
Stakeholders Directly Impacted
Goals and Performance Highlights
Commitment, Challenge and Opportunity
Conducting business with a commitment to ethics, morality, and honesty is the foundation of a transparent and sustainable organization. Combating corruption, strictly complying with the law, and properly paying taxes not only reflect social responsibility and accountability to stakeholders but also help build trust from customers, investors, and external service providers, as well as promoting a strong organizational culture. Responsible business conduct leads to a good reputation, strong relationships with stakeholders, and meaningful participation in sustainable social development – all of which are key factors that support stable growth and long-term competitiveness. The company has policies and management guidelines on business ethics issues, with important policies published on the company’s website.
Management and Operational Approach
The group has announced the implementation of the Good Corporate Governance Policy, the Business Ethics Policy, and the Anti-Corruption Policy, recognizing the importance of promoting efficient operations and sustainable growth to maximize benefits for shareholders and take all stakeholders into account.
The company is committed to monitoring and managing risks, as well as encouraging executives and employees to work with transparency and fairness, to build confidence that we adhere to the principles of good corporate governance for listed companies, with a focus on ethical, transparent, and verifiable operations. This will help the company to continue growing sustainably while considering the benefits to society and the environment. The company also regularly reviews its Good Corporate Governance Policy, Business Ethics Policy, and Anti-Corruption Policy to ensure alignment with the changing business environment.
The group has established operational guidelines based on the principles of transparency, ethics, and systematic accountability, in alignment with good corporate governance principles for listed companies, through relevant policies, to build trust with all stakeholders. Furthermore, the group has signed a Memorandum of Understanding (MoU) on Ethical Criteria for Drug Promotion with domestic pharmaceutical manufacturers. In 2024, the Company participated in the Corporate Governance Report (CGR) assessment for listed companies and received a total score of 76 points, which is considered good. Additionally, the group has studied guidelines from the Thai Private Sector Collective Action Coalition Against Corruption (CAC) to adapt and enhance quality, transparency, and fairness in operations.
Currently, the group has outlined operational guidelines that are ethical, transparent, and verifiable, in accordance with the good corporate governance principles for listed companies, through relevant policies such as the Good Corporate Governance Policy, the Business Code of Conduct, and the Anti-Corruption Policy.
Additionally, the group has established safe and reliable channels for reporting violations or witnessing corrupt practices. Whistleblowers or complainants are protected appropriately to ensure fair consideration and protection for all reports, as follows:
A review process has been established along with protective and remedial measures for whistleblowers or complainants in accordance with the company’s defined whistleblowing and complaint policy.
